Skip to content

Does Use of a Pre-Procedure Educational Video for Urodynamic Testing Reduces Anxiety?

Use of a Pre-Procedure Educational Video for Urodynamic Testing as a Tool to Reduce Anxiety: A Prospective Randomized Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07740629
Acronym
VIDEO-U
Enrollment
60
Registered
2026-07-31
Start date
2026-08-01
Completion date
2027-05-01
Last updated
2026-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Bladder Overactive, Urinary Incontinence, Urinary Incontinence , Stress

Keywords

Urinary Incontinence, Urodymanics, Video, Stress, Cortisol

Brief summary

The objective of this randomized prospective study is to evaluate whether viewing an educational video before urodynamic testing reduces anxiety among women undergoing evaluation for pelvic floor or urinary symptoms. The primary research question is: Does viewing a short educational video before urodynamic testing reduce objective and subjective anxiety levels and improve the overall testing experience? Participants scheduled to undergo urodynamic testing as part of routine clinical care will be randomly assigned to either an educational video intervention or standard pre-procedure counseling alone. Participants will complete brief questionnaires, provide saliva samples for cortisol measurement as an objective biomarker of stress, and report anxiety and pain levels before, during, and after urodynamic testing.

Detailed description

his study examines whether viewing a short educational video before urodynamic testing reduces anxiety, embarrassment, and discomfort, and improves participants' understanding of the procedure. Urodynamic testing evaluates bladder and urethral sphincter function, and many women experience stress before undergoing the examination. Eligible participants are women whose treating physician has recommended urodynamic testing as part of the evaluation of urinary or pelvic floor symptoms. Participation in the study is entirely voluntary. Following informed consent, participants will meet with a member of the research team, who will explain the purpose of the study and the urodynamic procedure. Participants will then be randomly assigned to either an educational video intervention group or a standard verbal explanation group. Before the procedure, participants will complete brief questionnaires assessing stress level, coping style, and demographic and clinical characteristics. A saliva sample will be collected for cortisol measurement as an objective biomarker of stress, and blood pressure and heart rate will be recorded. During urodynamic testing, participants will rate anxiety and pain using a numerical rating scale from 1 to 10, and an additional saliva sample will be collected. After completion of the examination, participants will complete a brief questionnaire evaluating the overall experience, including anxiety, embarrassment, and discomfort. The total duration of study-related procedures, including urodynamic testing, is approximately one hour. No additional medical risks are anticipated beyond those associated with standard urodynamic testing. Some participants may experience minor discomfort when answering personal questions or providing saliva samples. No additional procedural risks are expected. Although individual benefit cannot be guaranteed, participation may improve preparation for urodynamic testing and reduce anxiety or discomfort. The knowledge gained from this study may contribute to improving the care of future patients undergoing urodynamic evaluation. All study data will be coded and maintained confidentially to protect participant privacy. Access to identifiable information will be limited to the investigators and authorized regulatory authorities, in accordance with applicable regulations. No identifying information will appear in reports or publications. Participation is voluntary, and participants may decline participation or withdraw from the study at any time without affecting current or future medical care.

Interventions

OTHERvideo

A short video explaining the urodynamics test.

Sponsors

Yair Daykan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* women 18 years and above, undergoing a urodynamics test

Exclusion criteria

* women under SSRI/SNRI treatment women with a known anxiety disorder women who had a previous urodynamics test

Design outcomes

Primary

MeasureTime frameDescription
Anxiety represented by cortisol levelsthrough study completion, an average of 1 hourComparison between levels of salivary cortisol concentrations before and at the end of the urodynamics test, between the two groups. Cortisol level in nmol/L . the higher difference show increase in stress level

Secondary

MeasureTime frameDescription
Heart rate and subjective questionnairesthrough study completion, an average of 1 hourComparison between levels of heart rate and subjective anxiety level questionnaire scores, before and during the urodynamics test, between the two groups.

Countries

Israel

Contacts

CONTACTyair daykan, Dr
yair.dykan@gmail.com+972542198231

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 5, 2026